Found: 31
Select item for more details and to access through your institution.
Polyethylene glycol 20 kDa-induced vacuolation does not impair phagocytic function of human monocyte-derived macrophages.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.894411
- By:
- Publication type:
- Article
Pain and functional disability amongst adults with moderate and severe haemophilia from the Irish personalised approach to the treatment of haemophilia (iPATH) study.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 6, p. 518, doi. 10.1111/ejh.13763
- By:
- Publication type:
- Article
In vitro field study and worldwide survey assessing how clinical haemostasis laboratories analyse recombinant and plasma‐derived von Willebrand factor products.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 151, doi. 10.1111/hae.14892
- By:
- Publication type:
- Article
A cross‐sectional follow‐up study of physical activity in adults with moderate and severe haemophilia.
- Published in:
- Haemophilia, 2023, v. 29, n. 3, p. 892, doi. 10.1111/hae.14775
- By:
- Publication type:
- Article
Physical activity, physical fitness and cardiometabolic risk amongst adults with moderate and severe haemophilia.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 72, doi. 10.1111/hae.14653
- By:
- Publication type:
- Article
A systematic review of physical activity in people with haemophilia and its relationship with bleeding phenotype and treatment regimen.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 544, doi. 10.1111/hae.14282
- By:
- Publication type:
- Article
Biological mechanisms underlying inter‐individual variation in factor VIII clearance in haemophilia.
- Published in:
- Haemophilia, 2020, v. 26, n. 4, p. 575, doi. 10.1111/hae.14078
- By:
- Publication type:
- Article
PEGylated Biopharmaceuticals.
- Published in:
- Toxicologic Pathology, 2015, v. 43, n. 7, p. 959, doi. 10.1177/0192623315591171
- By:
- Publication type:
- Article
Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease.
- Published in:
- Journal of Blood Medicine, 2022, v. 13, p. 649, doi. 10.2147/JBM.S377126
- By:
- Publication type:
- Article
Ethanol dependence of α<sub>1</sub>-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases.
- Published in:
- Transfusion, 2008, v. 48, n. 2, p. 314, doi. 10.1111/j.1537-2995.2007.01525.x
- By:
- Publication type:
- Article
Biochemical, molecular characterization, and glycoproteomic analyses of α<sub>1</sub>-proteinase inhibitor products used for replacement therapy.
- Published in:
- Transfusion, 2006, v. 46, n. 11, p. 1959, doi. 10.1111/j.1537-2995.2006.01004.x
- By:
- Publication type:
- Article
Plasma procurement and plasma product safety in light of the COVID‐19 pandemic from the perspective of the plasma industry.
- Published in:
- Vox Sanguinis, 2022, v. 117, n. 6, p. 780, doi. 10.1111/vox.13267
- By:
- Publication type:
- Article
Reply to Farrugia: Appropriately specifying the quality of plasma for fractionation.
- Published in:
- Vox Sanguinis, 2022, v. 117, n. 3, p. 460, doi. 10.1111/vox.13185
- By:
- Publication type:
- Article
Biochemical and cellular markers differentiate recovered, in‐line filtered plasma, and plasma obtained by apheresis methods.
- Published in:
- Vox Sanguinis, 2022, v. 117, n. 1, p. 27, doi. 10.1111/vox.13118
- By:
- Publication type:
- Article
Mutation of the surface-exposed amino acid Trp<sup>2313</sup> to Ala in the FVIII C2 domain results in defective secretion of the otherwise functional protein.
- Published in:
- British Journal of Haematology, 2004, v. 125, n. 5, p. 629, doi. 10.1111/j.1365-2141.2004.04959.x
- By:
- Publication type:
- Article
SHORT REPORT Evaluation of the haemostatic potential of factor VIII-heparin cofactor II hybrid proteins in a mouse model.
- Published in:
- British Journal of Haematology, 2003, v. 123, n. 4, p. 692, doi. 10.1046/j.1365-2141.2003.04674.x
- By:
- Publication type:
- Article
Activation and inactivation of human factor X by proteases derived from Ficus carica.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 4, p. 1042, doi. 10.1046/j.1365-2141.2002.03954.x
- By:
- Publication type:
- Article
Structural analysis of the recombinant therapeutic product rFVIII and its PEGylated variants using 2-D DIGE.
- Published in:
- Electrophoresis, 2011, v. 32, n. 11, p. 1292, doi. 10.1002/elps.201000627
- By:
- Publication type:
- Article
Microchip capillary gel electrophoresis of multiply PEGylated high-molecular-mass glycoproteins.
- Published in:
- Biotechnology Journal, 2012, v. 7, n. 5, p. 635, doi. 10.1002/biot.201100407
- By:
- Publication type:
- Article
Comprehensive glyco-proteomic analysis of human α1-antitrypsin and its charge isoforms.
- Published in:
- Proteomics, 2006, v. 6, n. 11, p. 3369, doi. 10.1002/pmic.200500751
- By:
- Publication type:
- Article
Factor Xa and Prothrombin: Mechanism of Action of FEIBA.
- Published in:
- Vox Sanguinis, 1999, v. 77, p. 72, doi. 10.1111/j.1423-0410.1999.tb00020.x
- By:
- Publication type:
- Article
Factor Xa and Prothrombin: Mechanism of Action of FEIBA.
- Published in:
- Vox Sanguinis, 1999, v. 77, p. 72, doi. 10.1159/000056722
- By:
- Publication type:
- Article
Effect of High- versus Intermediate-Purity Blood Coagulation Factor Concentrates on HIV-1 Replication.
- Published in:
- Vox Sanguinis, 1996, v. 70, n. 4, p. 195, doi. 10.1111/j.1423-0410.1996.tb01325.x
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2001
- By:
- Publication type:
- Letter
Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Preclinical safety and efficacy of a new recombinant FIX drug product for treatment of hemophilia B.
- Published in:
- International Journal of Hematology, 2013, v. 98, n. 5, p. 525, doi. 10.1007/s12185-013-1448-z
- By:
- Publication type:
- Article
Genotyping of the prion protein gene at codon 129.
- Published in:
- Acta Neuropathologica, 1999, v. 97, n. 4, p. 355, doi. 10.1007/s004010050998
- By:
- Publication type:
- Article
Structural analysis of the recombinant therapeutic product rFVIII and its PEGylated variants using 2-D DIGE.
- Published in:
- Proteomics - Clinical Applications, 2011, v. 5, n. 9/10, p. 573, doi. 10.1002/prca.201190095
- By:
- Publication type:
- Article
In vivo and in vitro processing of recombinant pro-von Willebrand factor.
- Published in:
- Histochemistry & Cell Biology, 2002, v. 117, n. 2, p. 123, doi. 10.1007/s00418-001-0375-x
- By:
- Publication type:
- Article
Polyethylene Glycol Exposure with Antihemophilic Factor (Recombinant), PEGylated (rurioctocog alfa pegol) and Other Therapies Indicated for the Pediatric Population: History and Safety.
- Published in:
- Pharmaceuticals (14248247), 2018, v. 11, n. 3, p. 75, doi. 10.3390/ph11030075
- By:
- Publication type:
- Article
Proteomic analysis of UVC irradiation-induced damage of plasma proteins: Serum amyloid P component as a major target of photolysis
- Published in:
- FEBS Letters, 2006, v. 580, n. 13, p. 3229, doi. 10.1016/j.febslet.2006.05.002
- By:
- Publication type:
- Article